Publications | CESAR l Center for Substance Abuse Research l University of Maryland

Using Hospital Electronic Health Records to Monitor Drug Use Trends in Emergency Department PatientsBradford Schwartz, MD, Eric D. Wish, PhD, Amy Billing, MSSA, Julie Factor, BA, Ebonie Massey, MA, & E. Erin Artigiani, MA EDDS-EHR-MD-PrinceGeorges-UMPGHC-May2019.pdf618.18 KB
Using Hospital Electronic Health Records to Monitor Drug Use Trends in Emergency Department Patients at the University of Maryland Prince George’s Hospital CenterBradford Schwartz, MD, Eric D. Wish, PhD, Amy Billing, MSSA, Julie Factor, BA, Ebonie Massey, MA, & E. Erin Artigiani, MA Cerner_Bulletin_May2019_0.pdf621.93 KB
DEA Emerging Threat Report: First Quarter 2019Drug Enforcement Administration (DEA) Special Testing and Research Laboratory
DEWS Methodology OverviewBilling, A.S., Artigiani, E.E., Hippolyte, T., and Wish, E.D. (2019). Drug Early Warning Signals (DEWS): Methodology Overview. Office of National Drug Control Policy. Washington, DC: Executive Office of the President. DEWS-Methodology-Overview-March-2019.pdf1.37 MB
Drug Early Warning Signals (DEWS): Operation PAR – North Fort Myers, Florida.Wish, E.D., Billing, A.S., Artigiani, E.E, and Hippolyte, T. (2019). Drug Early Warning Signals (DEWS): Operation PAR – North Fort Myers, Florida. Office of National Drug Control Policy. Washington, DC: Executive Office of the President. DEWS-Operation-PAR-March-2019-Final.pdf1.02 MB
Drug Early Warning Signals (DEWS): Serenity Lane - Coburg, OregonBilling, A.S., Artigiani, E.E, Hippolyte, T., and Wish, E.D. (2019). Drug Early Warning Signals (DEWS): Serenity Lane - Coburg, Oregon. Office of National Drug Control Policy. Washington, DC: Executive Office of the President. DEWS-Serenity-Lane-March-2019-Final.pdf1.06 MB
Using Electronic Health Records to Track Emerging Drug Problems in Baltimore (February 2019)Zachary D.W. Dezman, MD, Daniel L. Lemkin, MD, J. Kathleen Tracy, PhD, Eric D. Wish, PhD, Amy Billing, MSSA, Julie Factor, BA, Ebonie Massey, MA, & E. Erin Artigiani, MA MPower_EpicBulletin_Feb2019_Revised_0.pdf443.65 KB
Using Hospital Electronic Health Records to Monitor Drug Use Trends in Overdose Patients (February 2019)Zachary D.W. Dezman, MD, Daniel L. Lemkin, MD, J. Kathleen Tracy, PhD, Eric D. Wish, PhD, Amy Billing, MSSA, Julie Factor, BA, Ebonie Massey, MA, & E. Erin Artigiani, MA EDDS-EHR-MD-Baltimore-Feb2019.pdf443.61 KB
DEA Emerging Threat Report: Annual 2018Drug Enforcement Administration (DEA) Special Testing and Research Laboratory DEA-Emerging-Threat-Report-2018-Annual.pdf404.56 KB
DEA Emerging Threat Report: Fourth Quarter 2018Drug Enforcement Administration (DEA) Special Testing and Research Laboratory DEA-Emerging-Threat-Report-2018-Quarter-4.pdf270.34 KB
DOTS Issue 8 - Methamphetamine and New Psychoactive Substances Detected in Specimens from Pretrial Services Agency for the District of Columbia dotsbulletin-issue8-october2018-dcpsa_0.pdf148.3 KB
DEA Emerging Threat Report: Third Quarter 2018Drug Enforcement Administration (DEA) Special Testing and Research Laboratory dea-emerging-threat-report-2018-quarter-3.pdf159.93 KB
Methamphetamine: A Regional Drug Crisis (2018)NDEWS Sentinel Community Epidemiologists ndews-scs-methamphetamine-report-september-2018-final_0.pdf1.16 MB
DOTS Issue 7 - Methamphetamine, but No Fentanyl, Found in Opiate-Positive Specimens from a Corpus Christi, Texas, Residential Treatment Center; Multiple Drugs Found in Every Specimen dotsbulletin-issue7-august2018-charliesplacetx-final_0.pdf299.55 KB
CDEWS Reports: Drug Early Warning from Re-Testing Biological Samples: Allen County, Indiana. Office of National Drug Control Policy. Washington, DC: Executive Office of the President. Wish, E.D., Billing, A.S., and Artigiani, E.E. (2018) finalreport_cdews4_inv36.pdf1.82 MB
CDEWS Reports: Drug Early Warning from Re-Testing Biological Samples: Jefferson/Lincoln/Pulaski/Rockcastle Counties, Kentucky. Office of National Drug Control Policy. Washington, DC: Executive Office of the President.Wish, E.D., Billing, A.S., and Artigiani, E.E. (2018). finalreport_cdews4_kyv43.pdf1.93 MB
DEA Intelligence Report: Slang Terms and Code Words: A Reference for Law Enforcement Personnel (2018)Drug Enforcement Administration (DEA) dea-drug-slang-terms-and-code-words-july2018.pdf1.35 MB
DOTS Issue 5 - Uninsured Opioid Users Admitted to Medication-Assisted Treatment (MAT) Program in Palm Beach County, Florida, Found to Be Using Many Drugs in Addition to Opioids dots-bulletin-issue5-july2018-palmbeach-mat-final_0.pdf159.28 KB
DOTS Issue 6 - No Fentanyl Analogs but Buprenorphine, Naloxone, and Marijuana Detected in Specimens from Suspected Users of Fentanyl in Vermont dotsbulletin-issue6-july2018-aspenti-final_0.pdf121.62 KB
Drug Early Warning from Re-Testing Biological Samples: Maryland Hospital Study; Office of National Drug Control Policy. Washington, DC: Executive Office of the President. Wish, E.D., Billing, A.S., Artigiani, E.E., Dezman, Z., Schwartz, B., and Pueschel, J. (2018). FinalReport_CDEWS4_ED_Maryland-Hospital-Study.pdf2.62 MB
DEA Emerging Threat Report: Mid Year 2018Drug Enforcement Administration (DEA) Special Testing and Research Laboratory dea-emerging-threat-report-2018-mid-year.pdf426.96 KB
DEA Emerging Threat Report: Second Quarter 2018Drug Enforcement Administration (DEA) Special Testing and Research Laboratory dea-emerging-threat-report-2018-quarter-2.pdf361.4 KB
DOTS Issue 1 - Overview of the Drug Outbreak Testing Service Pilot Study dotsbulletin-issue1-june2018-methodology-final_0.pdf97.59 KB
DOTS Issue 2 - First DOTS Study Finds Fentanyl and Polydrug Use in Patients Seen During Opioid Overdose Spike in Baltimore – Higher Doses of Naloxone May Be Needed dotsbulletin-issue2-june2018-baltimore-midtown-final_0.pdf160.4 KB
DOTS Issue 3 - Methamphetamine, Opioids, Cocaine, and Multiple Drugs Were Most Common in Specimens from Seattle/King County Area Decedents dotsbulletin-issue3-june2018-kingcomedicalex-final_0.pdf190.22 KB